EBITDA (Quarterly)

EBITDA: Income before interest, taxes, depreciation and amortization.

Dr. Reddy's Laboratories Ltd (RDY) had EBITDA of $98.00M for the most recently reported fiscal quarter, ending 2026-06-30.

Quarterly Annual

Figures for fiscal quarter ending 2026-06-30

Income Statement Financials
Revenue	$853.00M
Net Income	$47.00M
Cost of Goods Sold	$456.00M
Gross Profit	$397.00M
Operating Expenses	$812.00M
Operating Income	$41.00M
Non-Operating Income/Expense	$18.00M
Pre-Tax Income	$58.00M
Normalized Pre-Tax Income	$58.00M
Income after Taxes	$46.00M
Income from Continuous Operations	$46.00M
Consolidated Net Income/Loss	$46.00M
Normalized Income after Taxes	$46.00M
EBIT	$41.00M
EBITDA	$98.00M
Weighted-Average Shares Outstanding (Basic)	783.33M
Weighted-Average Shares Outstanding (Diluted)	783.33M
Earnings per Share (EPS) (Basic)	$0.06
Earnings per Share (EPS) (Diluted)	$0.06
Balance Sheet Financials
Current Assets	$3.16B
Property, Plant, and Equipment	$1.22B
Long-Term Assets	$2.92B
Total Assets	$6.08B
Current Liabilities	$1.66B
Long-Term Debt	$126.00M
Long-Term Liabilities	$330.00M
Total Liabilities	$1.99B
Common Equity	$4.08B
Tangible Shareholders Equity	$2.86B
Shareholders Equity	$4.09B
Common Shares Outstanding	834.68M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-10.00M
Cash Flow from Investing Activities	$41.00M
Cash Flow from Financial Activities	$-74.00M
Beginning Cash	$162.00M
End Cash	$119.00M
Increase/Decrease in Cash	$-43.00M
Stock-Based Compensation	$1.00M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.90
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.03
Debt to Equity Ratio	0.19
Gross Margin	46.54%
Operating Margin	4.81%
EBIT Margin	4.81%
EBITDA Margin	--
Pre-Tax Profit Margin	6.80%
Profit Margin	5.51%
Free Cash Flow	$-42.00M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.14
Inventory Turnover	0.54
Receiveable Turnover	0.80
Days Sales in Receivables	112.05
Return on Equity	1.13%
Return on Tangible Equity	1.61%
Return on Assets	0.76%
Return on Investments	1.09%
Book Value Per Share	$4.90
Free Cash Flow per Share	$-0.05
Operating Cash Flow per Share	$-0.01

Data from Zacks Investment Research, Inc.